Skip to content

A comparative study of the intervention effects of different neuromodulation techniques in individuals with heroin addiction.

A comparative study of the intervention effects of different neuromodulation techniques in individuals with heroin addiction.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104266
Enrollment
Unknown
Registered
2025-06-13
Start date
2025-06-25
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heroin addiction

Interventions

rTMS group:Repetitive transcranial magnetic stimulation (true versus sham stimulation)
tACS group:Transcranial alternating current stimulation (true versus sham stimulation)

Sponsors

School of Psychology, Northwest Normal University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1. Heroin addict with positive urine test results for opioids, negative urine test results for methamphetamine and other drugs, and assessed by an addiction psychiatrist at a drug rehabilitation hospital using a stereotyped clinical interview with DSM-5, no mixed drug use (i.e., heroin only), and no hallucinations or acute withdrawal symptoms; 2. Not receiving any form of treatment, including medication and non-invasive brain stimulation, no mixed drug use (i.e., heroin only), no hallucinations or acute withdrawal symptoms, no history of psychiatric illness or family history, such as schizophrenia and bipolar disorder; 3. Male health control group recruited through community advertising, with no history of alcohol or substance abuse disorder, psychiatric disorder, and cardiovascular disease; 4. Both groups of subjects were right-handed, and their visual acuity was normal or corrected. Screening criteria for the intervention include: 1. Do not mix new synthetic drugs such as methamphetamine, cocaine, and ephedra except heroin; 2. No neurological, cardiovascular, or other diseases; 3. No metallic foreign bodies or medical devices implanted in the body; 4. No acute physical or mental illness; 5. Willingness to overcome heroin use; 6. No hallucinations or acute withdrawal symptoms.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: Heroin addicts included in this study were excluded if they suffered from any serious physical illness (e.g., stroke, epilepsy, cranial trauma), or had a neurologic disorder such as an Axis I disorder (e.g., depression, bipolar disorder, schizophrenia) that met the DSM-5 criteria, or if there was a history of psychiatric illness or family history. Exclusion Criteria for Intervention: Has been treated with substitute medication such as substitution methadone after withdrawal, has experienced hallucinations or acute withdrawal symptoms within the previous week, has a history of cranial trauma, stroke, or epilepsy, has significant physical disability and infectious disease, has a metallic medical device implanted in the body, and has received rTMS or transcranial direct current stimulation treatment previously.

Design outcomes

Primary

MeasureTime frame
Craving;Indicators of brain function;

Secondary

MeasureTime frame
Questionnaire standardized scores;Behavioral indicators;

Countries

China

Contacts

Public ContactXiaobin Ding

School of Psychology, Northwest Normal University

251467850@qq.com+86 150 9539 0723

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026